ProQuad

ProQuad Dosage/Direction for Use

Manufacturer:

Merck Sharp & Dohme
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Dosage/Direction for Use
Dosage: Individuals 12 - 23 months of age should receive a first dose of ProQuad administered subcutaneously.
If a second dose of measles, mumps, rubella, and varicella vaccine is needed, ProQuad may be used. This dose is usually administered at 4 to 6 years of age.
If the first dose of a measles-containing vaccine is given between 6 months of age and less than 12 months of age (in an at-risk situation such as measles outbreak, or due to official recommendations) the response to the vaccine may be adversely influenced by circulating maternal antibodies. Therefore, another dose of measles-containing vaccine should be given at 12 months of age or later. A subsequent (third) dose can be administered if warranted by official recommendations for measles-containing vaccine.
At least 1 month should elapse between a dose of measles vaccine or M-M-R II and ProQuad. If for any reason a second dose of varicella-containing vaccine is required, at least 1 month should elapse between administration of the 2 doses.
Do not give immune globulin (IG) or Varicella Zoster Immune Globulin (VZIG) concomitantly with ProQuad (see INTERACTIONS).
Method of Administration: For subcutaneous administration. Do not inject intravascularly.
The vaccine is to be injected in the deltoid region of the upper arm or in the higher anterolateral area of the thigh.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in